Pharmacological Evaluation of Prunus armeniaca Leaf Extracts for type 2 diabetes and associated complications
International Journal of Drug Delivery Technology · 11.06.2026 · 16 (52s)
DOI: 10.25258/ijddt.16.52s.80 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Sheetal Choudhary und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The present study investigated the antidiabetic activity and associated complications (inflammation and diabetic nephropathy) of Prunus armeniaca leaves extract. The ethyl acetate extract (EAPA) and methanol extract (MOPA) were selected for pharmacological evaluation after acute toxicity studies. Anti-inflammatory activity was assessed using the carrageenan-induced rat paw edema model, while analgesic activity was evaluated using the hot plate method. Antidiabetic activity was studied in streptozotocin-induced diabetic rats, followed by estimation of fasting blood glucose, glycosylated hemoglobin (HbA1c), and renal biomarkers (blood urea nitrogen and serum creatinine). Both extracts demonstrated significant and dose-dependent pharmacological activities. In the anti-inflammatory study, MOPA (200 mg/kg) showed the strongest inhibition of paw edema, approaching the effect of indomethacin, particularly in the late inflammatory phase. Analgesic evaluation revealed a time-dependent increase in reaction time, with MOPA (200 mg/kg) producing analgesic activity comparable to aspirin. In diabetic rats, both extracts significantly reduced fasting blood glucose levels and HbA1c, with MOPA (200 mg/kg) showing near-normalization comparable to the standard drug. Additionally, both extracts improved renal biomarkers, indicating protection against diabetic nephropathy, with methanol extract showing superior efficacy. The findings suggest that Prunus armeniaca possesses potent anti-inflammatory, analgesic, antihyperglycemic, and nephroprotective properties, likely due to the presence of polar phytoconstituents such as flavonoids and phenolic compounds. These results support the potential of the plant as a promising natural therapeutic candidate for the management of diabetes and its associated complications.
Zitieren
APA
Choudhary, S., & Dhaker, K. S. (2026). Pharmacological Evaluation of Prunus armeniaca Leaf Extracts for type 2 diabetes and associated complications. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.80
Vancouver
Choudhary S, Dhaker KS. Pharmacological Evaluation of Prunus armeniaca Leaf Extracts for type 2 diabetes and associated complications. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.80
BibTeX
@article{Choudhary2026,
author = {Choudhary, Sheetal and Dhaker, Kehar Singh},
title = {Pharmacological Evaluation of Prunus armeniaca Leaf Extracts for type 2 diabetes and associated complications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {52s},
doi = {10.25258/ijddt.16.52s.80}
}
EUVIMED